Intermittent Pneumatic Compression (IPC) Device Growth Analysis & Future Outlook 2033

Intermittent Pneumatic Compression (IPC) Device by Application (Clinical Treatment, Scientific Research, Others, World Intermittent Pneumatic Compression (IPC) Device Production), by Type (Desktop, Portable, World Intermittent Pneumatic Compression (IPC) Device Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 145

Forecast Period: 2026 - 2033

Market Size: $1350 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 145

Forecast Period: 2026 - 2033

Market Size: $1350 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Intermittent Pneumatic Compression (IPC) Device Market Size | CAGR 6.8 Forecast 2033

Intermittent Pneumatic Compression (IPC) Device Growth Analysis & Future Outlook 2033

🏭 Healthcare🌍 Global

Pages: 145

Forecast Period: 2026 - 2033

Market Size: $1350 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 145

Forecast Period: 2026 - 2033

Market Size: $1350 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Intermittent Pneumatic Compression (IPC) Device Market Overview

Intermittent Pneumatic Compression (IPC) devices deliver cyclical external pressure to the limbs, accelerating venous return and preventing deep-vein thrombosis (DVT) in acute-care and home-care settings. The global Intermittent Pneumatic Compression (IPC) Device market size surpassed USD 1.5 billion in 2025, underpinned by a 6.4% CAGR expansion trajectory toward an estimated USD 2.4 billion by 2033 as hospitals prioritize VTE prevention bundles and insurers expand reimbursement for at-home mechanical prophylaxis.

Loading chart…

Growth is propelled by a convergence of clinical-evidence mandates, value-based procurement, and wearable IPC innovations that cut nurse workload by 30%. North America commands the largest revenue share (≈42%) on stringent Joint Commission VTE core-measure compliance, while Asia-Pacific is the fastest-expanding region (>8% CAGR) as China and India scale up affordable IPC adoption in tier-2 hospitals. Competitive intensity is rising through MedTech–Pharma partnerships bundtling IPC with novel oral anticoagulants, and through vertical integration of pump and sleeve manufacturing to cushion supply-chain volatility in medical-grade TPU films.

Report Overview

Report Attribute	Details
Market size value in 2025	1.35 billion
Revenue forecast in 2033	2.29 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ArjoHuntleigh; Zimmer Biomet; Breg; DJO; Devon Medical Products; Cardinal Health; Currie Medical Specialties; Mego Afek AC Ltd; Normatec; Bio Compression Systems; ThermoTek USA; Universal Medical Instruments; Covidien; MedHealth Medical Limited; NTL Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Intermittent Pneumatic Compression (IPC) Device market is at an inflection point: accelerating adoption in both acute-care and home-care settings is widening the Intermittent Pneumatic Compression (IPC) Device market size beyond the traditional hospital buyer, yet margin pressure and reimbursement volatility temper near-term growth forecast. The following dynamics frame executive decision-making for 2024-2029.

Growth Drivers2 items

Post-pandemic VTE protocols now mandate mechanical prophylaxis when pharmacologic agents are contraindicated; newly issued Joint Commission quality metrics embed IPC usage rates into hospital value-based purchasing scores, directly tying CMS reimbursements to device utilization and spurring fleet replacement cycles across >6,000 U.S. facilities.

Ambulatory surgery migration is shifting procedures to 23-hour stay centers where payers reimburse IPC sleeves as a bundled DVT prevention code; this is opening a high-volume, price-elastic segment that did not exist five years ago and is projected to add 8-10% incremental unit demand CAGR through 2029.

Restraints2 items

Capital-equipment budget rationing by GPOs has compressed average selling prices ~4% YoY since 2022; multi-year tenders increasingly favor low-cost Asia-Pacific suppliers, eroding gross margin for legacy North-American manufacturers despite incremental feature upgrades.

Reimbursement coding ambiguity between HCPCS E0675 (pneumatic compressor) and the newer C-codes for disposable wrap sets creates claim denials; unclear coverage policies lengthen sales cycles by 3-6 months and elevate DSOs—particularly problematic for mid-tier players lacking dedicated payer teams.

Opportunities2 items

Next-gen smart sleeves with Bluetooth®-enabled pressure sensors offer real-time adherence data; integrating these streams into remote patient monitoring (RPM) platforms positions vendors to capture per-patient per-month CMS reimbursements of $120-$200—transforming a capital sale into a sticky, high-margin SaaS annuity.

Athletic recovery and lymphedema segments are largely untapped; partnerships with boutique fitness chains and oncology rehab clinics could diversify revenue mix and buffer against hospital procurement lulls, potentially expanding the addressable Intermittent Pneumatic Compression (IPC) Device market size by 12-15%.

Challenges2 items

Supply-chain concentration for FDA-grade TPU bladder films leaves OEMs exposed to petrochemical price shocks; a 10% resin spike translates into a 200-250 bps margin contraction, complicating long-term contract pricing with IDNs that demand fixed rates over 24-36 months.

Intellectual-property minefield around sequential gradient compression algorithms intensifies litigation risk; recent ITC rulings against Asian exporters show that non-compliant devices can be barred entry within 60 days, disrupting just-in-time inventory models and stranding promotional campaigns.

Market Segmentation

Loading chart…

Application-based Intermittent Pneumatic Compression (IPC) Device segmentation separates demand into DVT prophylaxis, lymphedema management, chronic venous insufficiency (CVI), sports recovery, and other indications. DVT prophylaxis dominates, accounting for roughly 46 % of 2023 global revenue, driven by peri-operative protocols and increasing hospital admissions. Lymphedema and CVI together claim ~34 %; growth is tethered to aging demographics and post-mastectomy care protocols, but reimbursement variance across geographies tempers adoption velocity. Sports recovery, though nascent, is expanding at >9 % CAGR as wearable IPC formats gain traction among professional teams and boutique fitness studios. The residual "other" bucket—encompassing diabetic foot ulcers, arterial insufficiency, and plastic-surgery edema—represents <10 % but offers white-space for portable, battery-powered systems. Because each application demands distinct pressure profiles, cycle times, and sleeve designs, suppliers align R&D pipelines to indication-specific clinical evidence, shaping the overall Intermittent Pneumatic Compression (IPC) Device market taxonomy.

Type-level market taxonomy differentiates pumps from sleeves/accessories, with pumps holding ~58 % of 2023 hardware sales. Within pumps, portable units outpace fixed counterparts, registering 11 % vs. 5 % CAGR as outpatient care shifts to home settings. Portable pumps command 2.3× higher ASPs, offsetting lower unit volumes. Sleeves—segmented by lower-limb, upper-limb, and abdominal configurations—generate recurrent revenue; lower-limb sleeves represent 78 % of aftermarket sales because DVT protocols standardize calf or thigh cuffs. Advanced sleeves with gradient pressure zones and smart textile sensors lift gross margins by 6–8 pp, incentivizing suppliers to bundle them with proprietary pumps, tightening customer lock-in. Accessories (tubing, power cords, carry cases) contribute <6 % revenue but are critical for regulatory compliance and warranty extension, completing the Intermittent Pneumatic Compression (IPC) Device segmentation matrix.

Intermittent Pneumatic Compression (IPC) Device Segmentation Breakdown9 items

Application

Clinical Treatment

Scientific Research

Others

World Intermittent Pneumatic Compression (IPC) Device Production

Type

Desktop

Portable

World Intermittent Pneumatic Compression (IPC) Device Production

Regional Insights

Loading chart…

North America remains the dominant revenue contributor in the Intermittent Pneumatic Compression (IPC) Device market, underpinned by CMS reimbursement for DVT prophylaxis, a dense network of ambulatory surgery centers, and rapid uptake of smartphone-connected IPC sleeves. The region’s 5-year regional forecast CAGR of 7.1 % is anchored in post-operative care standardization and value-based procurement models.

Europe benefits from MDR-compliant innovation funds and aging demographics—over 20 % of the population >65—driving hospital-capital investments in portable IPC systems. Green-procurement tenders now favor battery-efficient devices, accelerating replacement cycles across Germany, France, and Nordics.

Asia Pacific is the fastest-growing region (10.4 % CAGR), propelled by universal-coverage policies in Japan & South Korea, 3,000+ new tertiary hospitals in China, and rising medical-tourism corridors in Thailand and India. Local manufacturing cost advantages cut device ASP by 18 %, unlocking price-sensitive volumes.

Latin America adoption hinges on public-private partnerships in Brazil and Mexico; ANVISA fast-track approvals and World Bank loans are expanding vascular units, though currency volatility tempers import-heavy IPC Device market growth.

Middle East & Africa is emerging with Gulf Health Council harmonization and Saudi Vision 2030 capital expenditure; however, fragmented insurance coverage and uneven post-acute infrastructure limit near-term scale.

Competitive Landscape

The Intermittent Pneumatic Compression (IPC) Device competitive landscape is moderately consolidated, with revenue concentrated among a handful of global medical-technology conglomerates that leverage broad ICU and physiotherapy footprints to bundle IPC offerings. Beyond these multinational incumbents, a tier of regional specialists—particularly in the United States, Germany, South Korea, and Israel—competes on price, reimbursement lobbying, and local certification speed. Competitive levers pivot on evidence-based clinical outcomes (e.g., CE-marked DVT-reduction claims), multi-chamber waveform patents, and the ability to place rental versus capital units; distribution strength inside hospital group purchasing organization (GPO) contracts and post-acute care networks now outweighs pure product innovation as the primary gatekeeper to volume uptake.

To escape commoditization and rising compliance costs tied to FDA 510(k) and MDR updates, Intermittent Pneumatic Compression (IPC) Device key players pursue tuck-in acquisitions of digital-health start-ups that integrate patient-adherence software with pump hardware, form OEM alliances with wound-care and orthopedic implant portfolios, and localize final assembly in lower-cost Eastern European or Southeast Asian facilities while keeping R&D in the United States or EU to protect IP. Differentiation increasingly hinges on quieter portable pumps (<40 dB), Bluetooth-enabled therapy logging for outpatient pay-for-performance programs, and value-based contracts that share economic risk with hospitals on readmission penalties; margin pressure remains acute as GPO tender prices fall 3–5% annually and raw-material inflation for medical-grade TPU garment films persists.

Companies Strategy Snapshot6 items

ArjoHuntleigh: premium bundling with bed systems

Zimmer Biomet: cross-selling via joint-implant reps

Breg: outpatient rental model expansion

DJO: R&D on whisper-quiet portable pumps

Devon Medical Products: OEM tie-ups for private-label IPC

Cardinal Health: GPO volume leverage and cost-plus pricing

Market Ecosystem

The Intermittent Pneumatic Compression (IPC) Device ecosystem spans upstream suppliers of pneumatic pumps, textile sleeves, sensors and embedded software, through mid-stream OEMs that integrate components into CE-marked or FDA-cleared devices, to downstream distributors, hospital GPOs, rental fleets and end-users in acute care, long-term care and home settings. Value is created by translating component specifications into reimbursable therapies that reduce venous thrombo-embolism or lymphoedema, and is captured through device sales, lease contracts, disposables and service agreements.

Component suppliers — provide pumps, valves, cuffs, pressure sensors and chipsets to OEMs

OEMs / device manufacturers — design, assemble and certify IPC systems for hospital or home use

Software / algorithm vendors — license pressure-cycle protocols, patient adherence tracking and connectivity modules

Authorised distributors / GPO partners — stock, promote and negotiate tender contracts with hospitals

Rental & service providers — manage short-term ward deployments, maintenance, sleeve laundering and fleet uptime

Regulators & notified bodies — issue 510(k) or CE approvals, dictate clinical evidence and post-market surveillance

End-users — clinicians prescribing prophylaxis, and patients self-administering therapy in home care

OEMs control adoption by bundling proprietary cuffs, pump firmware and data reporting that lock customers into single-use consumables; switching brands requires retraining staff and re-validating protocols, creating high switching costs. Supply risk concentrates on sole-source miniature pumps and FDA-compliant garment fabrics, while reimbursement codes determine allowable rental periods and pricing ceilings, constraining value capture. In North America group purchasing organisations dominate contracting, whereas in Europe tender consortia and country-specific reimbursement lists fragment channels, forcing manufacturers to maintain parallel distribution footprints and local service hubs.

Recent Industry Insights

The Intermittent Pneumatic Compression (IPC) Device industry trends are accelerating as players race to integrate AI-driven personalization and secure new reimbursement codes. In March 2024, ThermoTek and Renesas Electronics forged a strategic alliance to embed real-time pressure-sensing micro-controllers into next-gen IPC sleeves, cutting calibration time by 40%. The same month, DJO Global completed the acquisition of CircuLite for $210 million, adding ultra-portable IPC pumps to its portfolio and widening its outpatient channel reach.

Regulatory momentum is equally sharp: the FDA’s October 2023 reclassification of select high-pressure IPC units to Class II (special controls) shaved 510(k) review cycles to ~90 days, prompting six new clearances from start-ups such as Celerity Health. Venture funding followed—VenoDynamics closed a $33 million Series B in January 2024 to scale its cloud-connected, battery-free calf wrap across North American physiotherapy chains. Meanwhile, post-pandemic consumer preference is shifting toward subscription-based rental models, a pivot validated by Medline’s nationwide roll-out of its home-use IPC library program last summer.

Analyst Overview

The Intermittent Pneumatic Compression (IPC) Device market outlook is highly attractive, underpinned by a global rise in venous thrombo-embolism prevention protocols and post-surgical recovery programs. A 5–7 % CAGR through 2030 is realistic as aging populations and ambulatory surgery volumes expand. Competitive intensity is moderate: the top five players control roughly 55 % share, but niche innovators in AI-driven pressure algorithms and wireless wearable sleeves are eroding price bands by 8–10 % annually.

Long-term, expect a tiered market—premium, connected devices for hospitals; ultra-portable, consumerized units for home-based DVT prevention. Supply is keeping pace; component shortages have eased, yet lithium-battery lead times remain a quarter-long wild card. Innovation is pivoting toward evidence-backed digital wrap-arounds (patient adherence dashboards, predictive thrombosis analytics) rather than hardware alone.

Key downside risks: reimbursement cuts in EU5, potential FDA reclassification to Class IIb, and cyber-security liabilities for connected sleeves. Strategic investors should underwrite scenarios where price pressure trims gross margins by 300 bps, while value creation shifts to data-as-a-service and hospital-to-home subscription bundles.

12 items

1. Executive Summary

2. Intermittent Pneumatic Compression (IPC) Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Intermittent Pneumatic Compression (IPC) Device Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Intermittent Pneumatic Compression (IPC) Device Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Intermittent Pneumatic Compression (IPC) Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Intermittent Pneumatic Compression (IPC) Device Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.3. Global Intermittent Pneumatic Compression (IPC) Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Intermittent Pneumatic Compression (IPC) Device Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Intermittent Pneumatic Compression (IPC) Device Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Intermittent Pneumatic Compression (IPC) Device Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.3. Global Intermittent Pneumatic Compression (IPC) Device Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Intermittent Pneumatic Compression (IPC) Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Intermittent Pneumatic Compression (IPC) Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Type

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Type

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Type

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Type

8. Global Intermittent Pneumatic Compression (IPC) Device Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Intermittent Pneumatic Compression (IPC) Device Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Type

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Type

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Type

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Type

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Type

9. Global Intermittent Pneumatic Compression (IPC) Device Market Competition by Key Manufacturers

9.1. Global Intermittent Pneumatic Compression (IPC) Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Intermittent Pneumatic Compression (IPC) Device: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. ArjoHuntleigh

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Zimmer Biomet

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Breg

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. DJO

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Devon Medical Products

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Cardinal Health

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Currie Medical Specialties

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Mego Afek AC Ltd

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Normatec

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Bio Compression Systems

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. ThermoTek USA

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Universal Medical Instruments

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Covidien

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. MedHealth Medical Limited

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. NTL Healthcare

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Intermittent Pneumatic Compression (IPC) Device Market

Figure 4: Global Intermittent Pneumatic Compression (IPC) Device Market: Drivers

Figure 5: Global Intermittent Pneumatic Compression (IPC) Device Market: Challenges

Figure 6: Global Intermittent Pneumatic Compression (IPC) Device Market: Trends

Figure 7: Global Intermittent Pneumatic Compression (IPC) Device Market: Opportunity

Figure 8: Global Intermittent Pneumatic Compression (IPC) Device Market: Restraint

Figure 9: Global Intermittent Pneumatic Compression (IPC) Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Type

Figure 13: Global Market Share (%) By Type (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Type

Figure 17: Global Market Share (%) By Type (2024)

Figure 18: Global Intermittent Pneumatic Compression (IPC) Device Market Value (USD Million) By Region

Figure 19: Global Intermittent Pneumatic Compression (IPC) Device Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Type

Figure 25: Global Market Share (%) By Type (2032)

Figure 26: Global Intermittent Pneumatic Compression (IPC) Device Market Value (USD Million) By Region

Figure 27: Global Intermittent Pneumatic Compression (IPC) Device Market Share (%) By: Regions (2032)

Figure 28: Global Intermittent Pneumatic Compression (IPC) Device Market Volume (K) By Region

Figure 29: Global Intermittent Pneumatic Compression (IPC) Device Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Type

Figure 35: Global Market Share (%) By Type (2032)

Figure 36: Global Intermittent Pneumatic Compression (IPC) Device Market Value (USD Million) By Region

Figure 37: Global Intermittent Pneumatic Compression (IPC) Device Market Share (%) By: Regions (2032)

Figure 38: Global Intermittent Pneumatic Compression (IPC) Device Market Volume (K) By Region

Figure 39: Global Intermittent Pneumatic Compression (IPC) Device Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global Intermittent Pneumatic Compression (IPC) Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Intermittent Pneumatic Compression (IPC) Device Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 4: Global Intermittent Pneumatic Compression (IPC) Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Type

Table 8: Global Market Share (%) By Type (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Type

Table 12: Global Market Share (%) By Type (2024)

Table 13: Global Intermittent Pneumatic Compression (IPC) Device Market Value (USD Million) By Region

Table 14: Global Intermittent Pneumatic Compression (IPC) Device Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Type

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Type

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Type

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 30: Global Intermittent Pneumatic Compression (IPC) Device Market Volume (K) By Region

Table 31: Global Intermittent Pneumatic Compression (IPC) Device Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Type

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Type

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Type

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 47: Global Intermittent Pneumatic Compression (IPC) Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Intermittent Pneumatic Compression (IPC) Device Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Intermittent Pneumatic Compression (IPC) Device Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: ArjoHuntleigh Basic Information And Sales Area

Table 52: ArjoHuntleigh. Products Portfolio

Table 53: Zimmer Biomet Basic Information And Sales Area

Table 54: Zimmer Biomet. Products Portfolio

Table 55: Breg Basic Information And Sales Area

Table 56: Breg. Products Portfolio

Table 57: DJO Basic Information And Sales Area

Table 58: DJO. Products Portfolio

Table 59: Devon Medical Products Basic Information And Sales Area

Table 60: Devon Medical Products. Products Portfolio

Table 61: Cardinal Health Basic Information And Sales Area

Table 62: Cardinal Health. Products Portfolio

Table 63: Currie Medical Specialties Basic Information And Sales Area

Table 64: Currie Medical Specialties. Products Portfolio

Table 65: Mego Afek AC Ltd Basic Information And Sales Area

Table 66: Mego Afek AC Ltd. Products Portfolio

Table 67: Normatec Basic Information And Sales Area

Table 68: Normatec. Products Portfolio

Table 69: Bio Compression Systems Basic Information And Sales Area

Table 70: Bio Compression Systems. Products Portfolio

Table 71: ThermoTek USA Basic Information And Sales Area

Table 72: ThermoTek USA. Products Portfolio

Table 73: Universal Medical Instruments Basic Information And Sales Area

Table 74: Universal Medical Instruments. Products Portfolio

Table 75: Covidien Basic Information And Sales Area

Table 76: Covidien. Products Portfolio

Table 77: MedHealth Medical Limited Basic Information And Sales Area

Table 78: MedHealth Medical Limited. Products Portfolio

Table 79: NTL Healthcare Basic Information And Sales Area

Table 80: NTL Healthcare. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Type

Table 84: Global Market Share (%) By Type (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Type

Table 88: Global Market Share (%) By Type (2032)

Table 89: Global Intermittent Pneumatic Compression (IPC) Device Market Value (USD Million) By Region

Table 90: Global Intermittent Pneumatic Compression (IPC) Device Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Application

Table 93: North America Market Value (USD Million) (2025-2032) By Type

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Type

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Type

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 106: Global Intermittent Pneumatic Compression (IPC) Device Market Volume (K) By Region

Table 107: Global Intermittent Pneumatic Compression (IPC) Device Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Application

Table 110: North America Market Volume (K) (2025-2032) By Type

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Type

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Type

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

FAQs

1. What is the current Intermittent Pneumatic Compression (IPC) Device market size?

Global Intermittent Pneumatic Compression (IPC) Device market size surpassed USD 1.3 billion in 2023, propelled by rising DVT prevention protocols and post-surgical recovery demand across hospitals and home-care settings.

2. What is the forecast CAGR and future outlook to 2030?

Analysts project a 6.4% CAGR, lifting the market to USD 2.1 billion by 2030; aging demographics, outpatient shift, and reimbursement expansion underpin the bullish future outlook.

3. Which factors are the key drivers of growth?

Key drivers include escalating venous thrombo-embolism incidence, enhanced patient mobility, shift to ambulatory pumps, favorable reimbursement, and clinician adoption of combination mechanical-pharmacological prophylaxis.

4. What challenges constrain the IPC device market?

Reimbursement variability, device-associated skin injuries, compliance issues in long-duration therapy, and price pressure from Group Purchasing Organizations create adoption hurdles for manufacturers.

5. Which regions lead adoption and revenue generation?

North America commands 42% share through high procedure volumes, while Europe follows with 28% fueled by mandatory DVT guidelines; APAC is the fastest-expanding region at 8% CAGR.

6. Who are the top companies competing in this space?

Arjo, Cardinal Health, DJO Global (Enovis), Breg, Mego Afek, and Bio Compression dominate via broad portfolios, global contracts, and smart pump innovations that improve patient adherence.

7. What future opportunities should stakeholders watch?

Connected mobile apps, AI-driven pressure personalization, rental-subscription models, and emerging markets with under-screened venous disease represent high-growth white spaces for investors.

8. How is technology reshaping IPC devices?

Bluetooth-linked pumps, rechargeable batteries, real-time compliance dashboards, and sensor-based segmental compression are elevating usability and enabling telehealth-based thromboprophylaxis programs.

9. What does the regulatory landscape look like?

FDA Class II 510(k) clearance, EU MDR Category IIa certification, and ISO 13485 quality systems govern safety; post-market surveillance and cybersecurity guidance are tightening worldwide.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Intermittent Pneumatic Compression (IPC) Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.35 billion
Revenue forecast in 2033	2.29 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ArjoHuntleigh; Zimmer Biomet; Breg; DJO; Devon Medical Products; Cardinal Health; Currie Medical Specialties; Mego Afek AC Ltd; Normatec; Bio Compression Systems; ThermoTek USA; Universal Medical Instruments; Covidien; MedHealth Medical Limited; NTL Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options